about
Dengue: challenges for policy makers and vaccine developers.Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearanceLow antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesPolytopic vaccination with a live-attenuated dengue vaccine enhances B-cell and T-cell activation, but not neutralizing antibodies.PUBLIC HEALTH. Dengue vaccines at a crossroad.Evaluation of silver nanoparticles toxicity of Arachis hypogaea peel extracts and its larvicidal activity against malaria and dengue vectors.Dengue: A runaway epidemic and a bewildered public health worker.The US Military Commitment to Vaccine Development: A Century of Successes and Challenges.Ask the Experts: Surveillance of global dengue distribution
P2860
Q33624327-A2D6FB71-0C78-4524-94BC-5D0BD80CB945Q36363799-7A683990-A73F-4313-ADE2-DA72B64F6899Q37130999-0F19ACD1-5B2F-4F99-BD93-D7C3925DE152Q37723038-DBDC477D-30E0-4C1D-8057-F7EF912C69C7Q40132249-29EA74F5-B7C1-410E-9865-8B0338D94931Q40148276-25A769E9-680B-4784-A3DA-D991B4A15AEAQ40173003-447607D7-41A9-41AC-956E-87993D2703C6Q55432397-32F0BACE-DEE8-49B0-B07E-592E82F79BA7Q56797968-D925C2F5-5A10-43E8-9C72-22FD93C8394C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current issues in dengue vaccination.
@en
type
label
Current issues in dengue vaccination.
@en
prefLabel
Current issues in dengue vaccination.
@en
P1476
Current issues in dengue vaccination.
@en
P2093
Stephen J Thomas
Timothy P Endy
P304
P356
10.1097/01.QCO.0000433310.28771.CC
P577
2013-10-01T00:00:00Z